Scott Ohanesian
Mr. Scott Ohanesian has held executive roles over the past 14 years for Clinical Logistics Organizations and Contract Manufacturing Organizations (CMOs), managing global logistics for Phase I to Phase IV clinical trials.
He currently leads the QuickSTAT U.S. commercial operations team to build strategic relationships with pharmaceutical and biotech companies in order to provide comprehensive solutions for their global supply chain, ensuring product integrity and patient safety.
Prior to joining QuickSTAT, Scott managed the Asia Pacific commercial operations for Marken Limited, where he implemented the commercial strategy for his company in key markets, such as Australia, China, India, Japan, Singapore, South Korea, and Taiwan. Prior to that position, he was in a global strategic management role at a CMO, creating mutually beneficial partnership models.
He is trained and well versed in Good Manufacturing Practices, (GMP) and has helped create innovative logistics solutions for numerous new drug products--from formulation development through to commercialization, for pharmaceutical and biotech companies.
Scott is a graduate of Boston College with a Bachelor of Science in Finance and a Masters of International Law in Diplomacy from The Fletcher School at Tufts University, with affiliated course work at Harvard Law School and Harvard Business School.
Craig Ackerman
C. Anthony Altar, Ph.D.
Robin Tsai
Janina Krumbeck
Dr. Krumbeck has received her PhD at the University of Nebraska-Lincoln and has focused her research on gastrointestinal microbiology working on the development of novel synbiotic applications in order to understand microbial ecology and to improve health. At Zymo Research she is part of the microbiomics team which is working towards addressing current challenges in the microbiome research.
